A Daily Network publication
Explore the network
Wealth Advisor Daily
The advisor's edition — practice, portfolio, and the book.
Wednesday, October 7, 2026The Morning Brief →Sign in

Who holds NVAXNOVAVAX

7 funds on our shelf carry NOVAVAX — heaviest hand: PBE at 3.13% of its book.

FundWeightFund assetsShares held
PBEInvesco Biotechnology & Genome ETFACTIVE3.13%$423M1,245,901
IDNAiShares Genomics Immunology and Healthcare ETFINDEX1.70%$317M431,739
XBIState Street SPDR S&P Biotech ETFINDEX0.66%$10.3B7,501,632
IBBiShares Biotechnology ETFINDEX0.14%$10.6B1,185,691
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.12%$112M11,832
TECBiShares U.S. Tech Breakthrough Multisector ETFINDEX0.03%$520M15,231
VHTVanguard Health Care Index FundINDEX0.02%$19B427,310

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

Every weekday · 6:30 a.m. ET

The Morning Brief

The latest from Wealth Advisor Daily, in your inbox every weekday. Free.